Liver cancer rates are rising

The incidence of hepatocellular carcinoma (HCC) in the U.S.continues to soar, and it is likely remain on that trajectory for at least a couple of decades, largely because of the obesity and type 2 diabetes epidemics, as well as by infections with hepatitis virus types C and B. Researcher Dr. Alita Mishra has said “I think rates will increase for another 10-20 years.” She went on to say greater vigilance is therefore needed to spot incident cases early. Dr. Mishra also said “Patients with cirrhosis should undergo regular HCC screening regardless of the underlying cause,”

The rise of HCC has been associated with a rise in infections with hepatitis C virus. And many of these people don’t know they are infected, and it generally takes decades for them to develop HCC. Obesity and type 2 diabetes are the second big factor. Dr. Mishra has commented “Hepatitis C infections are now falling, so perhaps the rise in new HCC cases will eventually peak, but not if other factors like obesity and type 2 diabetes continue to push it up.” And she has noted that hospitalized patients with HCC “are getting sicker, more complicated, and have more comorbidities.” Vigilance is therefore advised in dealing with liver cancer.

The incidence of hepatocellular carcinoma (HCC) in the U.S.continues to soar, and it is likely remain on that trajectory for at least a couple of decades, largely because of the obesity and type 2 diabetes epidemics, as well as by infections with hepatitis virus types C and B. Researcher Dr. Alita Mishra has said “I think rates will increase for another 10-20 years.” She went on to say greater vigilance is therefore needed to spot incident cases early. Dr. Mishra also said “Patients with cirrhosis should undergo regular HCC screening regardless of the underlying cause,”

Source: Penile Implant Surgery in India

Press Release Pedia
Logo
Shopping cart